Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Inks Depression-Based Proteomic Collaboration With Mindsense

NEW YORK, Feb. 4 - Functional proteomics firm Hybrigenics will collaborate with biomarker company Mindsense Biosystems to identify markers and drug targets linked with depression, the two companies said.


Mindsense Biosystems has a portfolio of blood-based biomarkers for depression and wants to use proteomics and functional genomics to develop them. To that end, Hybrigenics will apply its high-throughput proteomics techniques to identify proteins that interact with Mindsense targets, and validate those proteins as targets through cell-based phenotypic assays.


Financial details of the arrangement were not revealed.


Mindsense, based in Rehovot, Israel, was launched in 1998 to develop technology invented at Ben Gurion University. It focuses on developing diagnostics for mental disorders.


Paris-based Hybrigenics provides functional genomics services for a range of biotech firms. Its in-house drug-development efforts include research into infectious diseases, cancer and metabolic disorders.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.